Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2023 Earnings Conference Call October 30, 2023 4:30 PM ET
Company Participants
Todd Friedman - Senior Director, Investor Relations
Christian Henry - President and Chief Executive Officer
Susan Kim - Chief Financial Officer
Conference Call Participants
Tejas Savant - Morgan Stanley
Kyle Mikson - Canaccord
Jack Meehan - Nephron Research
Eve Burstein - Bernstein
Matt Sykes - Goldman Sachs
Dan Brennan - TD Cowen
John Sourbeer - UBS
Sung Ji Nam - Scotiabank
Luke Sergott - Barclays
Operator
Good afternoon, everyone, and welcome to the PacBio Third Quarter 2023 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please also note, today's event is being recorded.
At this time, I'd like to turn the floor over to Todd Friedman, Senior Director of Investor Relations. Sir, please go ahead.
Todd Friedman
Thank you, Jamie. Good afternoon and welcome to PacBio’s third quarter 2023 earnings conference call.
Earlier today, we issued a press release outlining the financial results, we will be discussing on today's call, a copy of which is available on the Investors section of our website at www.pacb.com or as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.
With me today are Christian Henry, President and Chief Executive Officer and Susan Kim, Chief Financial Officer.
On today's call, we will be making forward-looking statements, including statements regarding predictions, progress, estimates, plans, intentions, guidance, and others, including expectations with respect to our growth potential, instrument and consumable sales and GAAP and non-GAAP growth guidance.
You should not place undue reliance on forward-looking statements because they are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or discussed. We refer you to our documents that we filed with the SEC, including our most recent forms 10-Q and 10-K, and our recent press release to better understand the risks and uncertainties that could cause actual results to differ. We disclaim any obligation to update or revise these forward-looking statements except as required by law.
During the call we will also present certain financial information on a non-GAAP basis. Non-GAAP information is not prepared under a comprehensive set of accounting rules and should only be used to supplement in understanding of the company's operating results as reported under U.S. GAAP. Management believes that non-GAAP financial measures, combined with U.S. GAAP financial measures, provide useful information to compare our performance relative to forecasts and strategic plans, and benchmark our performance externally against competitors. Reconciliations between historical U.S. GAAP and non-GAAP results are presented in tables within our earnings release.